- Home
- SNDX vs PLTK Comparison
SNDX vs PLTK Comparison
Compare SNDX & PLTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- PLTK
- Stock Information
- Founded
- SNDX 2005
- PLTK 2010
- Country
- SNDX United States
- PLTK Israel
- Employees
- SNDX N/A
- PLTK N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- PLTK EDP Services
- Sector
- SNDX Health Care
- PLTK Technology
- Exchange
- SNDX Nasdaq
- PLTK Nasdaq
- Market Cap
- SNDX 1.3B
- PLTK 1.4B
- IPO Year
- SNDX 2016
- PLTK 2021
- Fundamental
- Price
- SNDX $16.42
- PLTK $3.59
- Analyst Decision
- SNDX Strong Buy
- PLTK Buy
- Analyst Count
- SNDX 10
- PLTK 9
- Target Price
- SNDX $38.40
- PLTK $7.19
- AVG Volume (30 Days)
- SNDX 1.9M
- PLTK 2.4M
- Earning Date
- SNDX 11-04-2025
- PLTK 11-06-2025
- Dividend Yield
- SNDX N/A
- PLTK 11.14%
- EPS Growth
- SNDX N/A
- PLTK N/A
- EPS
- SNDX N/A
- PLTK 0.23
- Revenue
- SNDX $77,933,000.00
- PLTK $2,673,100,000.00
- Revenue This Year
- SNDX $642.36
- PLTK $9.56
- Revenue Next Year
- SNDX $108.58
- PLTK $2.86
- P/E Ratio
- SNDX N/A
- PLTK $15.54
- Revenue Growth
- SNDX 2126.66
- PLTK 4.98
- 52 Week Low
- SNDX $8.58
- PLTK $3.37
- 52 Week High
- SNDX $22.50
- PLTK $8.80
- Technical
- Relative Strength Index (RSI)
- SNDX 61.98
- PLTK 43.42
- Support Level
- SNDX $14.93
- PLTK $3.37
- Resistance Level
- SNDX $15.99
- PLTK $4.01
- Average True Range (ATR)
- SNDX 0.70
- PLTK 0.18
- MACD
- SNDX 0.04
- PLTK 0.02
- Stochastic Oscillator
- SNDX 83.26
- PLTK 31.31
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
About PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.